中国畜牧兽医 ›› 2025, Vol. 52 ›› Issue (3): 1281-1291.doi: 10.16431/j.cnki.1671-7236.2025.03.030

• 预防兽医 • 上一篇    

猪德尔塔冠状病毒感染与抗感染研究进展

毛福超1,2,3,4, 翟崇凯1,2,3,4, 田文静1,2,3,4, 王聪慧1,2,3,4, 宋敏杰1,2,3,4, 王迎鲜5, 张贺伟1,2,3,4   

  1. 1. 洛阳职业技术学院食品与药品学院, 洛阳 471003;
    2. 河南省动物疫病与公共卫生工程研究中心, 洛阳 471003;
    3. 河南省地标药材与生命健康工程研究中心, 洛阳 471003;
    4. 洛阳市动物病毒病诊断与免疫预防重点实验室, 洛阳 471003;
    5. 洛阳职业技术学院机电工程学院, 洛阳 471003
  • 收稿日期:2024-05-28 发布日期:2025-02-22
  • 通讯作者: 张贺伟
  • 作者简介:毛福超,E-mail:maofuchao202112@163.com。
  • 基金资助:
    河南省科技攻关项目(242102110041、232102111050);国家自然科学基金项目(32102640);洛阳市核心技术攻关类公益专项(2202034A)

An Updated Review of Porcine Deltacoronavirus in Terms of Infection and Anti-infection Research

MAO Fuchao1,2,3,4, ZHAI Chongkai1,2,3,4, TIAN Wenjing1,2,3,4, WANG Conghui1,2,3,4, SONG Minjie1,2,3,4, WANG Yingxian5, ZHANG Hewei1,2,3,4   

  1. 1. College of Food and Drugs, Luoyang Polytechnic, Luoyang 471003, China;
    2. Animal Diseases and Public Health Engineering Research Center of Henan Province, Luoyang 471003, China;
    3. The Geographical Indication Medicines and Life Health Engineering Research Center of Henan Province, Luoyang 471003, China;
    4. Luoyang Key Laboratory of Diagnosis and Immunoprophylaxis of Animal Viral Diseases, Luoyang 471003, China;
    5. Department of Mechanical and Electrical Engineering, Luoyang Polytechnic, Luoyang 471003, China
  • Received:2024-05-28 Published:2025-02-22

摘要: 猪德尔塔冠状病毒(Porcine deltacoronavirus,PDCoV)是一种新型肠道冠状病毒,主要感染哺乳仔猪,临床表现为腹泻、呕吐、脱水等症状,发病率可达100%。PDCoV严重危害新生仔猪健康,现已成为引起猪群腹泻的主要病原体之一。PDCoV通过膜融合及受体介导的内吞作用侵入宿主细胞,S蛋白是病毒侵入细胞的主要结构,表面氨基肽酶N、小窝蛋白是病毒侵入细胞的关键位点。此外,表面氨基肽酶N目前被认为是PDCoV跨物种传播的重要位点。细胞通过干扰素(IFN)基因表达、胆固醇代谢及N蛋白泛素化等途径引发抗感染。PDCoV通过自身结构蛋白、辅助蛋白及非结构蛋白等通过干扰IFN的表达及诱导侵染细胞凋亡等途径产生免疫逃避,进而持续侵染宿主细胞。目前用于预防和控制PDCoV感染的商业疫苗或抗病毒药物多在试验研发阶段或初上市阶段,其对PDCoV的预防和控制的临床效果亟需市场验证。尤其是针对病毒复制、免疫逃逸、抗PDCoV宿主因子等靶点开发的抗病毒药物或疫苗,为未来开发新型疫苗或抗病毒药物研发提供了新的研究方向和坚实的基础。笔者通过阐述PDCoV与宿主之间的感染和抗感染机制,探究多种抗病毒药物抑制PDCoV感染的潜在作用机制,为研究PDCoV致病机制、抗PDCoV感染治疗以及新药物的开发提供参考。

关键词: 猪德尔塔冠状病毒(PDCoV); 致病性; 免疫逃逸; 抗病毒机制

Abstract: Porcine deltacoronavirus (PDCoV),a novel enteric coronavirus,primarily infects suckling piglets,causing clinical symptoms such as diarrhea,vomiting and dehydration with a morbidity rate of up to 100%.PDCoV poses a significant threat to the health of newborn piglets and has become one of the primary pathogens causing diarrhea in swine.PDCoV enters host cells through membrane fusion and receptor-mediated endocytosis,with the S protein being the major structural protein for cell entry.Aminopeptidase N and caveolin on the cell surface have been identified as critical entry sites.Additionally,aminopeptidase N is currently considered a crucial determinant of PDCoV cross-species transmission.Host cells initiate an antiviral response through the expression of interferon (IFN) genes,cholesterol metabolism,and N protein ubiquitination.PDCoV evades the host immune response by interfering with IFN expression and inducing apoptosis of infected cells through its structural,accessory and non-structural proteins.Commercial vaccines or antiviral drugs for the prevention and control of PDCoV infection are currently in the experimental or early market stages,their clinical efficacy in preventing and controlling PDCoV infection still requires market validation.In particular,the development of antiviral drugs or vaccines targeting viral replication,immune evasion,and host factors against PDCoV provides new research directions and a solid foundation for the development of novel vaccines or antiviral drugs.By elucidating the infection and anti-infection mechanisms between PDCoV and the host,and investigating the potential mechanisms of various antiviral drugs in inhibiting PDCoV infection,this review provides a reference for studying the pathogenesis of PDCoV,antiviral therapy and the development of new drugs.

Key words: Porcine deltacoronavirus (PDCoV); pathogenicity; immune escape; antiviral mechanism

中图分类号: